News Details

25 10 2019

Cadila Healthcare has received USFDA approval

25/10/2019

Cadila Healthcare has received USFDA approval for Haloperidol Decanoate injection used in treatment of Schizophrenia. The product will be manufactured at Liva Pharma's Manufacturing facility at Vadodara. "Liva Pharmaceuticals Limited, a wholly-owned subsidiary company of Cadila Healthcare Limited.

Invite a Friend